De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome


Dravet syndrome is a severe epilepsy syndrome characterized by infantile onset of therapy-resistant, fever-sensitive seizures followed by cognitive decline.
Mutations in SCN1A explain about 75% of cases with Dravet syndrome; 90% of these mutations arise de novo.

Researchers have studied a cohort of nine Dravet-syndrome-affected individuals without an SCN1A mutation ( these included some atypical cases with onset at up to 2 years of age ) by using whole-exome sequencing in proband-parent trios.

In two individuals, researchers have identified a de novo loss-of-function mutation in CHD2 ( encoding chromodomain helicase DNA binding protein 2 ).
A third CHD2 mutation was identified in an epileptic proband of a second ( stage 2 ) cohort.

All three individuals with a CHD2 mutation had intellectual disability and fever-sensitive generalized seizures, as well as prominent myoclonic seizures starting in the second year of life or later.

To explore the functional relevance of CHD2 haploinsufficiency in an in vivo model system, researchers have knocked down chd2 in zebrafish by using targeted morpholino antisense oligomers. chd2-knockdown larvae exhibited altered locomotor activity, and the epileptic nature of this seizure-like behavior was confirmed by field-potential recordings that revealed epileptiform discharges similar to seizures in affected persons.
Both altered locomotor activity and epileptiform discharges were absent in appropriate control larvae.

The study has provided evidence that de novo loss-of-function mutations in CHD2 are a cause of epileptic encephalopathy with generalized seizures. ( Xagena )

Suls A et al, Am J Hum Genet 2013;93:967-975

XagenaMedicine_2013



Indietro

Altri articoli

Amyotrophic lateral sclerosis ( ALS ) is a rapidly progressing neurodegenerative disease that is characterized by motor neuron loss and...


Interim topline data from a randomized, double-blind, multicenter, exploratory phase 1b study evaluating the effects of oral Mongersen ( GED-0301...


Duchenne muscular dystrophy is caused by dystrophin deficiency and muscle deterioration and preferentially affects boys. Antisense-oligonucleotide-induced exon skipping allows synthesis...


Phase IIa clinical trial data on ATL1102 were published in the medical journal Neurology. The article highlights the successful outcomes...


Crohn’s disease-related inflammation is characterized by defective activity of the immunosuppressive cytokine transforming growth factor ( TGF )-beta1, due to...


On 13 December 2012, the Committee for Medicinal Products for Human Use ( CHMP ) has adopted a negative opinion,...


The stability and propagation of hepatitis C virus ( HCV ) is dependent on a functional interaction between the HCV...


A new type of treatment significantly reduces the severity of muscle weakness in myasthenia gravis, giving hope for a new...


Researchers have developed a successful strategy for interfering with Ebola virus infection that protected 75 percent of nonhuman primates exposed...